2016 Q1 Form 10-Q Financial Statement

#000114420416099287 Filed on May 05, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.430M $1.710M
YoY Change 42.11% 52.68%
% of Gross Profit
Research & Development $8.155M $6.494M
YoY Change 25.58% 139.01%
% of Gross Profit
Depreciation & Amortization $37.00K $8.000K
YoY Change 362.5% 166.67%
% of Gross Profit
Operating Expenses $8.155M $8.207M
YoY Change -0.63% 113.78%
Operating Profit -$10.58M -$8.207M
YoY Change 28.93% 113.78%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$497.0K -$4.151M
YoY Change -88.03% -415200.0%
Pretax Income -$10.58M -$8.207M
YoY Change 28.93% 113.78%
Income Tax
% Of Pretax Income
Net Earnings -$11.08M -$12.36M
YoY Change -10.36% 222.02%
Net Earnings / Revenue
Basic Earnings Per Share -$0.12 -$0.17
Diluted Earnings Per Share -$0.12 -$0.17
COMMON SHARES
Basic Shares Outstanding 90.83M shares 72.67M shares
Diluted Shares Outstanding 90.83M shares 72.67M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.10M $12.05M
YoY Change 25.31% 7.97%
Cash & Equivalents $15.10M $12.05M
Short-Term Investments
Other Short-Term Assets $7.116M $1.574M
YoY Change 352.1% 18.17%
Inventory
Prepaid Expenses $374.0K
Receivables
Other Receivables
Total Short-Term Assets $22.22M $13.62M
YoY Change 63.11% 9.1%
LONG-TERM ASSETS
Property, Plant & Equipment $500.0K $75.00K
YoY Change 566.67% 97.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.00K $20.00K
YoY Change 50.0% 100.0%
Total Long-Term Assets $520.0K $93.00K
YoY Change 459.14% 111.36%
TOTAL ASSETS
Total Short-Term Assets $22.22M $13.62M
Total Long-Term Assets $520.0K $93.00K
Total Assets $22.74M $13.72M
YoY Change 65.79% 9.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.600M $1.559M
YoY Change 195.06% 101.68%
Accrued Expenses $1.820M $2.646M
YoY Change -31.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.53M $15.34M
YoY Change 14.27% 1884.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $240.0K
YoY Change
Total Long-Term Liabilities $240.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $17.53M $15.34M
Total Long-Term Liabilities $240.0K $0.00
Total Liabilities $16.49M $15.34M
YoY Change 7.49% 1884.61%
SHAREHOLDERS EQUITY
Retained Earnings -$113.4M
YoY Change 33.26%
Common Stock $111.8M
YoY Change 15.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.260M -$1.625M
YoY Change
Total Liabilities & Shareholders Equity $22.74M $13.72M
YoY Change 65.79% 9.46%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$11.08M -$12.36M
YoY Change -10.36% 222.02%
Depreciation, Depletion And Amortization $37.00K $8.000K
YoY Change 362.5% 166.67%
Cash From Operating Activities -$5.674M -$5.458M
YoY Change 3.96% 57.29%
INVESTING ACTIVITIES
Capital Expenditures $44.00K $18.00K
YoY Change 144.44% 350.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$44.00K -$18.00K
YoY Change 144.44% 350.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$5.674M -$5.458M
Cash From Investing Activities -$44.00K -$18.00K
Cash From Financing Activities $0.00 $0.00
Net Change In Cash -$5.718M -$5.476M
YoY Change 4.42% 57.81%
FREE CASH FLOW
Cash From Operating Activities -$5.674M -$5.458M
Capital Expenditures $44.00K $18.00K
Free Cash Flow -$5.718M -$5.476M
YoY Change 4.42% 57.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
563000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
649000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5458000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
827000 USD
CY2015Q1 us-gaap Depreciation
Depreciation
8000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
37000 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26000 USD
CY2015Q1 syn Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
12000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1348000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2016Q1 syn Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.75
CY2015 syn Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriod
2448 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
63447 shares
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5674000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-44000 USD
CY2015Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-5476000 USD
CY2016Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-5718000 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-310000 USD
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
592000 USD
CY2016Q1 syn Stock Issued For Milestone Payments
StockIssuedForMilestonePayments
0 USD
CY2015Q1 syn Stock Issued For Milestone Payments
StockIssuedForMilestonePayments
-350000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
0 USD
CY2016Q1 syn Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
307000 USD
CY2015Q4 syn Prepaid Expenses Research And Development
PrepaidExpensesResearchAndDevelopment
643000 USD
CY2016Q1 us-gaap Prepaid Insurance
PrepaidInsurance
224000 USD
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
339000 USD
CY2016Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
425000 USD
CY2015Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
208000 USD
CY2016Q1 us-gaap Other Assets Current
OtherAssetsCurrent
7116000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9519000 USD
CY2016Q1 syn Prepaid Clinical Research Organizations
PrepaidClinicalResearchOrganizations
6160000 USD
CY2015Q4 syn Prepaid Clinical Research Organizations
PrepaidClinicalResearchOrganizations
8329000 USD
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
123000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
105000 USD
CY2015Q4 syn Accrued Manufacturing Costs
AccruedManufacturingCosts
0 USD
CY2016Q1 syn Accrued Manufacturing Costs
AccruedManufacturingCosts
2000 USD
CY2015Q4 syn Accrued Vendor Payments
AccruedVendorPayments
133000 USD
CY2016Q1 syn Accrued Vendor Payments
AccruedVendorPayments
388000 USD
CY2015Q4 syn Accrued Clinical Consulting Services
AccruedClinicalConsultingServices
164000 USD
CY2016Q1 syn Accrued Clinical Consulting Services
AccruedClinicalConsultingServices
556000 USD
CY2016Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
7300000 USD
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2016Q1 syn Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriod
0 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
50000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015 syn Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
1.6
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.79
CY2016Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90908234 shares
CY2016Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
6900000 USD
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5300000 USD
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
624000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
599000 USD
CY2015Q1 syn Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionExercisePrice
1.54
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.17 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.31 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0203 pure
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.77
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
277000 USD
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90826752 shares
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8992428 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6531106 shares
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17525000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12049000 USD
CY2015Q1 syn Warrant Liabilities
WarrantLiabilities
10900000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7974794 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7908899 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7858899 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.80
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.79
CY2016Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
355000 USD
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
0 USD
CY2016Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
248000 USD
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
153000 USD
CY2016Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
266000 USD
CY2015Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
124000 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
869000 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72673959 shares

Files In Submission

Name View Source Status
0001144204-16-099287-index-headers.html Edgar Link pending
0001144204-16-099287-index.html Edgar Link pending
0001144204-16-099287.txt Edgar Link pending
0001144204-16-099287-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
syn-20160331.xml Edgar Link completed
syn-20160331.xsd Edgar Link pending
syn-20160331_cal.xml Edgar Link unprocessable
syn-20160331_def.xml Edgar Link unprocessable
syn-20160331_lab.xml Edgar Link unprocessable
syn-20160331_pre.xml Edgar Link unprocessable
tpg12.jpg Edgar Link pending
v437694_10q.htm Edgar Link pending
v437694_ex31-1.htm Edgar Link pending
v437694_ex31-2.htm Edgar Link pending
v437694_ex32-1.htm Edgar Link pending
v437694_ex32-2.htm Edgar Link pending